Date de publication: 14 novembre 2007
Promoteur – Intermédiaire Financier
Viveris ManagementLieu
Description
The proposed operation consists in an equity participation under EC MEDA II risk capital resources in two compartments of AlterMed: AlterMed Maghreb investing primarily in Morocco; and AlterMed Alternative Private Equity Fund (APEF) investing primarily in Tunisia.
Objectifs
The two compartments in which the Bank intends to invest display innovative features. AlterMed Maghreb will target primarily leveraged buy-outs (LBOs), thereby supporting a niche not fully covered by other funds in Morocco. AlterMed APEF will support companies to be listed in the Tunisian alternative market, an initiative expected to be implemented by the end of 2007 and strongly supported by the Tunisian government as an opportunity to substantially increase the capitalisation of the stock market, still in its infancy stage.
Secteur(s)
Montant BEI envisagé (montant approximatif)
Up to EUR 11 million or 25% of the total commitments in any of the targeted compartments, whichever is lower.
Coût total (montant approximatif)
The target size of AlterMed Maghreb is expected to be EUR 25 million, and EUR 30 million for AlterMed APEF.
Aspects environnementaux
Not applicable
Passation des marchés
Not applicable
Statut
Signé - 13/12/2007